← Search organizationsOpenPolis
FDANonrulemakingFDA-2010-N-0218

Who commented on this docket

Considerations Regarding FDA Review and Regulation of Articles for the Treatment of Rare Diseases; Public Hearing

1 organizations filed 1 public comment on Considerations Regarding FDA Review and Regulation of Articles for the Treatment of Rare Diseases; Public Hearing, at the Food and Drug Administration. The comment window closed 5810d ago.

Organizations
1
Comments
1
RIN
—
Comment window
closed 5810d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.